This protocol is judged by an institutional assessment board, an independent group that evaluations any scientific trials involving humans. If a review requires a Agenda I drug, once the board approves the protocol as ethical, the researchers really need to submit an application for an investigational new drug (IND) amount within the FDA.“It’s